Generation of heterozygous (MRli003-A-3) and homozygous (MRli003-A-4) TRPM4 knockout human iPSC lines
Summary
TRPM4 is a Ca2+-activated channel mediating the transport of monovalent cations across the cell membrane. Mutations in the TRPM4 gene have been associated with cardiac arrhythmias in humans. Using CRISPR/Cas9 gene editing technology, we established two TRPM4 knockout human iPSC lines - one heterozygous (MRli003-A-3) and one homozygous (MRli003-A-4) - by inserting a frameshift mutation in exon 2 of the TRPM4 gene. Both lines maintained pluripotency, a normal karyotype, parental cell morphology, and the ability to differentiate into the three germ layers. Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
| Authors | Zhang F, Meier AB, Lipp P, Laugwitz KL, Dorn T, Moretti A |
|---|---|
| Journal | Stem cell research |
| Publication Date | 2022 Apr;60:102731 |
| PubMed | 35245852 |
| DOI | 10.1016/j.scr.2022.102731 |